Systemic and mucosal immunity is elicited after both intramuscular and intravaginal delivery of human immunodeficiency virus type 1 DNA plasmid vaccines to pregnant chimpanzees

Journal of Infectious Diseases

Volumn 180, Issue 4, 1999, Pages 1351-1355

  Bagarazzi, Mark L ^a   Boyer, Jean D ^b   Ali Javadian, M ^d   Chattergoon, Michael A ^b   Shah, Ami R ^e   Cohen, Adam D ^b   Bennett, Mosi K ^f   Ciccarelli, Richard B ^c   Ugen, Kenneth E ^g   Weiner, David B ^b  

^a ST CHRISTOPHER'S HOSPITAL FOR CHILDREN   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Wyeth Lederle Vaccines   (United States)

^d Alamogordo Primate Facility   (United States)

^e EMORY UNIVERSITY   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; GAG PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PLASMID VECTOR; POL PROTEIN; REV PROTEIN; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; BREAST FEEDING; CELLULAR IMMUNITY; CHIMPANZEE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; FETOMATERNAL TRANSFUSION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNITY; LYMPHOCYTE PROLIFERATION; MUCOSAL IMMUNITY; NONHUMAN; PLACENTAL TRANSFER; PREGNANCY; PRIORITY JOURNAL; VACCINATION; VIRUS TRANSMISSION;

ADMINISTRATION, INTRAVAGINAL; AIDS VACCINES; ANIMALS; DISEASE TRANSMISSION, VERTICAL; DNA, VIRAL; FEMALE; GENES, ENV; HIV INFECTIONS; HIV-1; HUMANS; INJECTIONS, INTRAMUSCULAR; PAN TROGLODYTES; PLASMIDS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; VACCINES, SYNTHETIC;

EID: 0033389282     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314978     Document Type: Article

References (15)

1. Boyer J, Ugen KE, Wang B, et al. Protection of chimpanzees from high dose heterologous HIV-1 challenge by DNA vaccination. Nat Med 1997; 3:526-32.
2. Boyer J, Ugen KE, Chattergoon M, et al. DNA vaccination as anti HIV immunotherapy in infected chimpanzees. J Infect Dis 1997; 176:1501-9.
3. MacGregor RR, Boyer JD, Ugen KE, et al. First human trial of a DNA-based vaccine for treatment of HIV-1: safety and host responses. J Infect Dis 1998; 178:92-100.
4. Wang B, Ugen KE, Srikantan V, et al. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1993; 90:4156-60.
5. Wang B, Boyer JD, Srikantan V, et al. DNA inoculation induces neutralizing immune responses against human immunodeficiency virus type 1 in mice and non-human primates. DMA Cell Biol 1993; 12:799-805.
6. Wang B, Boyer JD, Srikantan V, et al. Induction of humoral and cellular immune responses to the human immunodeficiency type-1 virus in non-human primates by in vivo DNA inoculation. Virology 1995; 211:102-12.
7. Bagarazzi ML, Boyer JD, Javadian MA, et al. Safety and immunogenicity of intramuscular and intravaginal delivery of HIV-1 DNA constructs to infant chimpanzees. J Med Primatol 1997; 26:27-33.
8. Shiver JW, Davies ME, Yasutomi Y, et al. Anti HIV env immunities elicited by nucleic acid vaccines. Vaccine 1997; 15:884-7.
9. Jansson M, Orlandi P, Scarlatti G, et al. Rule of immunity in maternal infant HIV-1 transmission. Acta Paediatr Suppl 1997; 421:39-45.
10. Wang B, Dang K, Agadjanyan MG, et al. Mucosal immunization with a DNA vaccine induces immune responses against HIV-1 at a mucosal site. Vaccine 1997; 15:821-5.
11. Lohman BL, McChesney MB, Miller CJ, Otsyula M, Berardi CJ, Marthas ML. Mucosal immunization with a live, virulence-attenuated simian immunodeficiency virus (SIV) vaccine elicits antiviral cytotoxic T lymphocytes and antibodies in rhesus macaques. J Med Primatol 1994; 23:95-101.
12. Girard M, van der Ryst E, Barre-Sinoussi F, et al. Challenge of chimpanzees immunized with a recombinant canarypox HIV-1 virus. Virology 1997; 232:98-104.
13. Hammond SA, Bollinger RC, Stanhope PE, et al. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines. J Exp Med 1992; 176:1531-42.
14. Lubeck MD, Natuk R, Myagkikh M, et al. Long-term protection of chimpanzees against high-dose HIV-1 challenge induced by immunization. Nat Med 1997; 3:651-8.
15. Kim J, Chattergoon M, Ayyavoo V, et al. Development of a multi-component candidate vaccine for HIV-1. Vaccine 1997; 15:879-83.